We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zacks Value Investor Highlights: Nu Skin Enterprises, VF Corp, Yamana Gold, Meritor and Vertex Pharmaceuticals
Read MoreHide Full Article
For Immediate Release
Chicago, IL – September 24, 2021 – Zacks Value Investor is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here:
5 Top-Ranked Stocks on Sale Right Now
Welcome to Episode #252 of the Value Investor Podcast.
Every week, Tracey Ryniec, the editor of Zacks Value Investor portfolio, shares some of her top value investing tips and stock picks.
Although the major stock indexes may only be a few percent off their all-time highs, some stocks have corrected much more.
It's not unusual for some stocks to be down 10%, 20% or even more.
That means some stocks are on sale.
But how do value investors find the best quality stocks that are also a buying opportunity?
Screening for Stocks on Sale
To screen for stocks with quality, include the Zacks Rank of #1 (Strong Buy) or #2 (Buy).
The top Zacks Rank usually means that Wall Street analysts are revising earnings estimates higher.
Zacks Screener on Zacks.com also includes a "price as a % of 52-week high-low range" option.
That means you can screen for stocks within, say, 10% of their 52-week high but you can also look for stocks within 10% of their 52-week lows.
How many stocks have both the top Zacks Ranks and are near their 52-week lows?
36 stocks have this disconnect.
It's rare.
5 Top Ranked Stocks that are on Sale Right Now
1. Nu Skin Enterprises, Inc. (NUS - Free Report) has fallen 28% in the last 3 months and is now at a new 52-week low. This beauty and wellness company does a lot of business in Asia which is making traders nervous due to the coronavirus outbreak there. But the analysts are holding firm on 2021 and 2022 earnings estimates, for now. It's cheap, with a forward P/E of just 9.4.
2. VF Corporation (VFC - Free Report) owns some of the hottest retail brands in Vans, North Face and Timberland. But shares are down 22.5% year-to-date and are at new 52-week lows. Yet earnings are expected to rise 150% this fiscal year and 16.3% next year. It trades with a PEG ratio of just 0.8, including there is both growth and value.
3. Yamana Gold , a gold miner, has slid 27.8% year-to-date. It will trade with the gold price. 4 estimates have been revised higher over the last 60 days. Shares are cheap, with a forward P/E of just 13.1.
4. Meritor is a global supplier of drivetrain, mobility, braking, aftermarket and electric powertrain solutions. Earnings are expected to soar 118% in fiscal 2021 and another 54% in fiscal 2022. 2 estimates were revised higher for both years in the last 2 months. No estimates have been cut. It's cheap, with a forward P/E of just 8.5 as shares have fallen 22.9% year-to-date.
5. Vertex Pharmaceuticals (VRTX - Free Report) is a large cap drug manufacturer. Shares are down 22% year-to-date as it trades within 1% of its 52-week low. Yet it's supposed to grow earnings by 19.9% in 2021 and another 6.2% in 2022. It trades with a forward P/E of just 15.
What else should you know about screening for stocks on sale?
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Zacks Value Investor Highlights: Nu Skin Enterprises, VF Corp, Yamana Gold, Meritor and Vertex Pharmaceuticals
For Immediate Release
Chicago, IL – September 24, 2021 – Zacks Value Investor is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here:
5 Top-Ranked Stocks on Sale Right Now
Welcome to Episode #252 of the Value Investor Podcast.
Every week, Tracey Ryniec, the editor of Zacks Value Investor portfolio, shares some of her top value investing tips and stock picks.
Although the major stock indexes may only be a few percent off their all-time highs, some stocks have corrected much more.
It's not unusual for some stocks to be down 10%, 20% or even more.
That means some stocks are on sale.
But how do value investors find the best quality stocks that are also a buying opportunity?
Screening for Stocks on Sale
To screen for stocks with quality, include the Zacks Rank of #1 (Strong Buy) or #2 (Buy).
The top Zacks Rank usually means that Wall Street analysts are revising earnings estimates higher.
Zacks Screener on Zacks.com also includes a "price as a % of 52-week high-low range" option.
That means you can screen for stocks within, say, 10% of their 52-week high but you can also look for stocks within 10% of their 52-week lows.
How many stocks have both the top Zacks Ranks and are near their 52-week lows?
36 stocks have this disconnect.
It's rare.
5 Top Ranked Stocks that are on Sale Right Now
1. Nu Skin Enterprises, Inc. (NUS - Free Report) has fallen 28% in the last 3 months and is now at a new 52-week low. This beauty and wellness company does a lot of business in Asia which is making traders nervous due to the coronavirus outbreak there. But the analysts are holding firm on 2021 and 2022 earnings estimates, for now. It's cheap, with a forward P/E of just 9.4.
2. VF Corporation (VFC - Free Report) owns some of the hottest retail brands in Vans, North Face and Timberland. But shares are down 22.5% year-to-date and are at new 52-week lows. Yet earnings are expected to rise 150% this fiscal year and 16.3% next year. It trades with a PEG ratio of just 0.8, including there is both growth and value.
3. Yamana Gold , a gold miner, has slid 27.8% year-to-date. It will trade with the gold price. 4 estimates have been revised higher over the last 60 days. Shares are cheap, with a forward P/E of just 13.1.
4. Meritor is a global supplier of drivetrain, mobility, braking, aftermarket and electric powertrain solutions. Earnings are expected to soar 118% in fiscal 2021 and another 54% in fiscal 2022. 2 estimates were revised higher for both years in the last 2 months. No estimates have been cut. It's cheap, with a forward P/E of just 8.5 as shares have fallen 22.9% year-to-date.
5. Vertex Pharmaceuticals (VRTX - Free Report) is a large cap drug manufacturer. Shares are down 22% year-to-date as it trades within 1% of its 52-week low. Yet it's supposed to grow earnings by 19.9% in 2021 and another 6.2% in 2022. It trades with a forward P/E of just 15.
What else should you know about screening for stocks on sale?
Listen to this week's podcast to find out.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com/performance
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.